Medical Device News Magazine

Ethicon Launches ECHELON ENDOPATH Staple Line Reinforcement: Reduces Complications Associated with Bariatric, Thoracic and General Surgical Procedures

Offers Significant Improvements Over Existing Buttressing Solutions

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Ethicon, part of Johnson & Johnson Medical Devices Companies, announced today the launch of ECHELON ENDOPATH Staple Line Reinforcement (SLR), a novel buttressing device designed to further strengthen staple lines and reduce potential complications during bariatric, thoracic and general surgical procedures. This is the company’s first buttress solution designed for use with its own industry-leading ECHELON FLEX™ Powered Staplers with GST reloads, which have been associated with a lower rate of air leaks and bleeding complications.[i],[ii] 

Ethicon developed the ECHELON ENDOPATH SLR to help surgeons who want even more strength around the staple line and to overcome issues with current buttressing options which can be difficult to load, result in inconsistent staple line coverage and may loosen with typical maneuvering during stapling procedures.

“The ECHELON ENDOPATH SLR takes a different approach to buttressing that offers significant improvements in ease of use, functionality and OR efficiency.[iii]  For those who buttress, I expect this will become their preferred solution,” said Neil Floch MD, FACS, Director of Minimally Invasive and Bariatric Surgery, Norwalk Hospital.***

Designed for ease of use, the ECHELON ENDOPATH SLR delivers a seamless buttress experience from start to finish.[iv] The device’s simple click-and-go applicator and proprietary buttress attachment material are designed for precise control, consistent and quicker loading, and a more secure attachment for uninterrupted tissue manipulation and release.[v] The new device prevents the slipping, twisting, sliding or bunching that can occur with other buttress options and provides greater stability when manipulating tissue.[vi]

The ECHELON ENDOPATH SLR also provides exceptional coverage after tissue manipulation. Studies show 100% of its applications covered all staples with buttress[vii] compared to 28%[viii] for GORE® SEAMGUARD® Bioabsorbable SLR and 0% for Medtronic’s Endo GIA™ Reinforced Reload with Tri-Staple Technology.[ix] The Ethicon device also showed higher average reinforcement,[x] and takes fewer steps and less time to load than the GORE product.[xi]

“The launch of the ECHELON ENDOPATH SLR marks a new milestone in Ethicon’s continuing commitment to provide a better way to staple, and now a better way to buttress, when needed in minimally-invasive surgical procedures,” said Tom O’Brien, Worldwide President Endomechanical, Ethicon, Inc.  “At Ethicon, we continually look for ways to optimize usability for surgeons and improve patient outcomes.”


[i] Miller DL, Roy S, Kassis ES. et al. Impact of powered and tissue-specific endoscopic stapling technology on clinical and economic outcomes of video-assisted thoracic surgery lobectomy procedures: a retrospective, observational study. Advances in Therapy (2018). https://doi.org/10.1007/s12325-018-0679-z.

[ii] Klassen C, Eckert CE, Wong J. et al. Ex Vivo Modeling of Perioperative Air Leaks in Porcine Lungs. IEEE Transactions on Biomedical Engineering (2018). https://ieeexplore.ieee.org/document/8325303/

[iii] Wong JB, Henninger DD, Clymer JW. et al. A Novel, Easy-to-Use Staple Line Reinforcement for Surgical Staplers. Medical Devices: Evidence and Research. 2020:12 23-29.

[iv] Based on coverage after manipulation assessment on porcine tissue.

[v] Based on coverage after manipulation assessment on porcine tissue.

[vi] Based on coverage after manipulation assessment on porcine tissue.

[vii] In a tissue test ECHELON ENDOPATH™ Reinforcement covered all staple legs in (40/40) applications compared to GORE™ SEAMGUARD™ (11/40), p<0.05.

[viii]  In a tissue test ECHELON ENDOPATH™ Reinforcement covered all staple legs in (40/40) applications compared to GORE™ SEAMGUARD™ (11/40), p<0.05.

[ix] In a tissue test ECHELON ENDOPATH™ Staple Line Reinforcement fully covered staple legs in (15/15) applications compared to Endo GIA™ Reinforced Reload with Tri-Staple™ Technology (0/15), p<0.05.

[x] Reinforcement measured via in vitro staple pull-through force at T=0, T=7, and T=14 days resulting in mean values: ECHELON ENDOPATH™ Reinforcement (22.02N, 10.65N, 2.93N) vs. GORE® SEAMGUARD® Reinforcement (7.33N, 5.52N, 2.35N), p<0.05. 109221-190311

[xi] Ricketts C, Pollack E. Evaluation of setup by nurses of a novel click and go staple line reinforcement system. Glob Surg. 2020;6. doi:10.15761/GOS.1000215.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”